Stock listing
NASDAQ:SXTP 60 Degrees Pharmaceuticals, Inc. Stock
Home listing (NASDAQ) of 60 Degrees Pharmaceuticals, Inc.
Follow 60 Degrees Pharmaceuticals, Inc. into a list and get an email when it puts out news.
Share price · NASDAQ:SXTP
$0.468 USD -0.070 (-13.0%)
Close on Nov 20, 2026
- Day range
- $0.460 – $0.500 USDNov 20, 2026
- Volume
- 51,287 sharesNov 20, 2026
- Market cap
- $2.10M USDAt the close on Nov 20, 2026 · price × 4.48M shares outstanding
- 52-week range
- $0.460 – $8.620 USDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
- Traded on an average day
- $333,873 USDMedian day 53,300 shares · last 3 months, Aug 20, 2026 – Nov 20, 2026

Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:SXTP · Home | $0.468 USD | -0.070 (-13.0%) | 51,287 | $0.500 | $0.500 | $0.460 | $0.538 | Close on Nov 20, 2026 |
Daily closes
Last 3 months, Aug 20, 2026 – Nov 20, 2026 · NASDAQ:SXTP · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $0.468 | -0.070 | -13.0% | $0.500 | $0.500 | $0.460 | 51,287 | |
| $0.538 | +0.004 | +0.7% | $0.534 | $0.538 | $0.481 | 34,018 | |
| $0.534 | +0.040 | +8.2% | $0.479 | $0.546 | $0.463 | 26,654 | |
| $0.494 | -0.024 | -4.7% | $0.510 | $0.510 | $0.480 | 52,945 | |
| $0.518 | -0.001 | -0.2% | $0.500 | $0.519 | $0.486 | 24,469 | |
| $0.519 | -0.001 | -0.2% | $0.519 | $0.540 | $0.493 | 61,936 | |
| $0.520 | 0.000 | -0.1% | $0.505 | $0.521 | $0.490 | 86,326 | |
| $0.521 | -0.026 | -4.7% | $0.558 | $0.600 | $0.480 | 105,885 | |
| $0.546 | -0.049 | -8.2% | $0.615 | $0.618 | $0.523 | 190,710 | |
| $0.595 | -0.321 | -35.0% | $0.673 | $0.674 | $0.553 | 359,100 | |
| $0.916 | -0.040 | -4.2% | $0.928 | $0.934 | $0.832 | 41,600 | |
| $0.956 | -0.054 | -5.3% | $1.010 | $1.010 | $0.916 | 45,600 | |
| $1.010 | +0.104 | +11.5% | $0.931 | $1.020 | $0.870 | 71,700 | |
| $0.906 | -0.034 | -3.6% | $0.948 | $0.948 | $0.827 | 46,000 | |
| $0.940 | -0.008 | -0.8% | $0.944 | $0.969 | $0.900 | 73,200 | |
| $0.948 | +0.101 | +11.9% | $0.802 | $1.000 | $0.799 | 355,900 | |
| $0.847 | +0.107 | +14.5% | $0.786 | $0.988 | $0.750 | 2,012,400 | |
| $0.740 | -0.128 | -14.7% | $0.869 | $0.872 | $0.588 | 16,421,000 | |
| $0.868 | -0.002 | -0.2% | $0.860 | $0.888 | $0.824 | 19,600 | |
| $0.870 | -0.006 | -0.7% | $0.821 | $0.930 | $0.821 | 13,100 | |
| $0.876 | -0.014 | -1.6% | $0.871 | $0.914 | $0.850 | 17,700 | |
| $0.890 | -0.032 | -3.5% | $0.941 | $0.950 | $0.870 | 24,200 | |
| $0.922 | +0.095 | +11.5% | $0.826 | $1.000 | $0.812 | 34,300 | |
| $0.827 | -0.028 | -3.3% | $0.861 | $0.900 | $0.820 | 40,300 | |
| $0.855 | -0.044 | -4.9% | $0.900 | $0.912 | $0.850 | 10,400 | |
| $0.899 | +0.019 | +2.2% | $0.880 | $0.900 | $0.835 | 37,300 | |
| $0.880 | -0.020 | -2.2% | $0.910 | $0.941 | $0.877 | 53,300 | |
| $0.900 | -0.016 | -1.7% | $0.887 | $0.942 | $0.875 | 37,500 | |
| $0.916 | -0.049 | -5.1% | $0.939 | $0.963 | $0.891 | 37,800 | |
| $0.965 | -0.008 | -0.8% | $0.960 | $0.996 | $0.910 | 41,100 | |
| $0.973 | -0.127 | -11.5% | $1.020 | $1.080 | $0.960 | 93,100 | |
| $1.100 | -0.010 | -0.9% | $1.060 | $1.160 | $1.008 | 153,800 | |
| $1.110 | -0.330 | -22.9% | $1.070 | $1.196 | $0.892 | 2,448,200 | |
| $1.440 | +0.050 | +3.6% | $1.550 | $1.660 | $1.361 | 626,000 | |
| $1.390 | +0.140 | +11.2% | $1.280 | $1.450 | $1.220 | 196,300 | |
| $1.250 | -0.080 | -6.0% | $1.290 | $1.390 | $1.230 | 137,200 | |
| $1.330 | +0.080 | +6.4% | $1.230 | $1.340 | $1.180 | 111,000 | |
| $1.250 | 0.000 | 0.0% | $1.270 | $1.300 | $1.210 | 146,500 | |
| $1.250 | +0.080 | +6.8% | $1.170 | $1.250 | $1.140 | 80,300 | |
| $1.170 | +0.020 | +1.7% | $1.160 | $1.170 | $1.120 | 35,000 | |
| $1.150 | -0.010 | -0.9% | $1.160 | $1.200 | $1.090 | 52,900 | |
| $1.160 | +0.120 | +11.5% | $1.040 | $1.160 | $1.040 | 53,800 | |
| $1.040 | +0.030 | +3.0% | $0.960 | $1.100 | $0.960 | 74,300 | |
| $1.010 | +0.054 | +5.6% | $0.980 | $1.020 | $0.940 | 24,200 | |
| $0.956 | -0.037 | -3.7% | $0.970 | $0.990 | $0.920 | 31,500 | |
| $0.993 | +0.069 | +7.5% | $0.960 | $1.040 | $0.850 | 179,900 | |
| $0.924 | +0.078 | +9.2% | $0.919 | $0.967 | $0.860 | 125,000 | |
| $0.846 | -0.053 | -5.9% | $0.900 | $0.900 | $0.840 | 61,900 | |
| $0.899 | -0.001 | -0.1% | $0.910 | $0.950 | $0.882 | 109,300 | |
| $0.900 | -0.030 | -3.2% | $0.961 | $0.961 | $0.900 | 57,800 | |
| $0.930 | -0.010 | -1.1% | $0.940 | $1.005 | $0.920 | 130,000 | |
| $0.940 | -0.037 | -3.8% | $0.980 | $1.000 | $0.930 | 30,600 | |
| $0.977 | +0.058 | +6.3% | $0.920 | $1.040 | $0.910 | 82,000 | |
| $0.919 | -0.011 | -1.2% | $0.930 | $0.989 | $0.897 | 57,800 | |
| $0.930 | -0.020 | -2.1% | $0.990 | $0.990 | $0.930 | 53,300 | |
| $0.950 | -0.070 | -6.9% | $1.030 | $1.050 | $0.900 | 105,200 | |
| $1.020 | -0.060 | -5.6% | $1.060 | $1.080 | $1.010 | 43,100 | |
| $1.080 | +0.050 | +4.9% | $1.030 | $1.090 | $1.010 | 40,700 | |
| $1.030 | -0.030 | -2.8% | $1.090 | $1.120 | $1.010 | 23,400 | |
| $1.060 | -0.020 | -1.9% | $1.080 | $1.115 | $1.050 | 46,600 | |
| $1.080 | -0.050 | -4.4% | $1.120 | $1.160 | $1.010 | 97,100 | |
| $1.130 | +0.050 | +4.6% | $1.120 | $1.130 | $1.050 | 18,700 | |
| $1.080 | -0.050 | -4.4% | $1.130 | $1.157 | $1.040 | 51,200 | |
| $1.130 | 0.000 | 0.0% | $1.150 | $1.150 | $1.090 | 17,600 | |
| $1.130 | 0.000 | 0.0% | $1.120 | $1.160 | $1.092 | 25,300 |
Splits
3 splits since 2024 · NASDAQ:SXTP · every price before a split is adjusted for it
| Day | Ratio | What |
|---|---|---|
| 1-for-4 | Consolidation | |
| 1-for-5 | Consolidation | |
| 1-for-12 | Consolidation |
- Ticker
- NASDAQ:SXTP
- Asset type
- Stock
- Exchange
- NASDAQ
- Currency
- USD
What changed lately
Latest news release · Nov 4, 2026
Join 60 Degrees Pharmaceuticals' Live Investor Webinar: Advancing Tafenoquine for Babesiosis While Expanding ARAKODA(R) Commercialization
Latest deck · Oct 23, 2026
2026 ILADS Annual Scientific Conference
Conference · 29 slides
Latest news
Join 60 Degrees Pharmaceuticals' Live Investor Webinar: Advancing Tafenoquine for Babesiosis While Expanding ARAKODA(R) Commercialization
Nov 4, 2026
Closed $0.916 (-4.2%) on Nov 5, 2026
60 Degrees Pharmaceuticals Announces Partnership with The University of Southern Mississippi to Evaluate Castanospermine in Nonclinical Models of Alpha-Gal Syndrome
Oct 28, 2026
Closed $0.847 (+14.5%) on Oct 28, 2026
60 Degrees Pharmaceuticals Announces Clinical Improvement and Negative PCR Results in All Completed Expanded Access Babesiosis Study Patients
Oct 27, 2026
Closed $0.74 (-14.7%) on Oct 27, 2026
60 Degrees Pharmaceuticals Plans January 2027 Hospitalized Babesiosis Data Readout; Will Seek Pre-sNDA Meeting with FDA
Oct 6, 2026
Closed $1.11 (-22.9%) on Oct 6, 2026
60 Degrees Pharmaceuticals and Exyn Technologies Interviews to Air Nationally on the RedChip Small Stocks, Big Money(TM) Show on CNBC and Bloomberg TV
Oct 2, 2026
Closed $1.39 (+11.2%) on Oct 2, 2026
60 Degrees Pharmaceuticals Announces Date for Hospitalized Babesiosis Study Interim Data Release and Key Opinion Leader Webinar
Oct 1, 2026
Closed $1.25 (-6.0%) on Oct 1, 2026
60 Degrees Pharmaceuticals Announces Participation in H.C. Wainwright 28th Annual Global Investment Conference
Sep 3, 2026
Closed $0.93 (-2.1%) on Sep 3, 2026
60 Degrees Pharmaceuticals Announces Second Quarter 2026 Results
Aug 17, 2026
Closed $1.08 (-9.6%) on Aug 17, 2026
60 Degrees Pharmaceuticals, Inc. Announces Private Placement Priced At-the-Market Under Nasdaq Rules
Jul 30, 2026
Closed $1.25 (-16.1%) on Jul 30, 2026
60 Degrees Pharmaceuticals, Inc. on 6ix
- News releases
- 25 in the last 12 months · 91 in all · newest Nov 4, 2026 · oldest 2023
- Decks
- 7 decks · latest Oct 23, 2026
Where 60 Degrees Pharmaceuticals, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:SXTP · Home listing · This page | NASDAQ | United States | USD |
| BOATS:SXTP | BOATS | United States | USD |
Valuation
Statements: 4 quarters to Sep 30, 2026 · price Nov 20, 2026
- Enterprise value
- $1.94M USD
- P/E
- Loss
- EV/sales
- 2.1×
- EV/EBITDA
- Negative EBITDA
- Price/book
- 2.5×
- Gross margin
- 24.1%
- Operating margin
- −971.7%
- Net margin
- −921.0%
- Debt to equity
- 0.2×
- Beta vs S&P 500
- 1.33
Forecasts
1 strong buy · 1 hold · Analysts' consensus from EODHD, read Nov 18, 2026. Not 6ix's view and not investment advice.
- Price target
- 3.70 USD · Analysts' mean
- EPS, year to Dec 2026
- -3.45 · 1 analyst
- Revenue, year to Dec 2026
- 1M · 2 analysts
Team and board
Officers
| Officer | Role |
|---|---|
| Geoffrey Dow | Chief Executive Officer & President |
| Tyrone Miller | Chief Financial Officer |
| Bryan Smith | Chief Medical Officer |
| Kristen Landon | Chief Commercial Officer |
Board
| Director | Role |
|---|---|
| Charles Allen | Director |
| Cheryl Xu | Director |
| Eric Francois | Director |
| Geoffrey Dow | Chief Executive Officer & President |
| Paul Field | Director |
| Stephen Toovey | Director |
Events
| Quarter | Results | Share move |
|---|---|---|
| Q3 2026 | Nov 16, 2026 · After close | +8.2% |
| Q2 2026 | Aug 14, 2026 · After close | −9.6% |
| Q4 2025 | Mar 30, 2026 · After close | +15.9% |
| Q3 2025 | Nov 13, 2025 · After close | −22.2% |
| Q2 2025 | Aug 13, 2025 · After close | −3.0% |
| Q1 2025 | May 15, 2025 · Before open | −4.4% |
| Q4 2024 | Feb 26, 2025 | −2.1% |
| Q3 2024 | Nov 14, 2024 · After close | −5.6% |
| Q2 2024 | Aug 14, 2024 · Before open | −1.5% |
| Q1 2024 | May 15, 2024 · After close | +4.7% |
All 13 quarters
| Quarter | Results | Share move |
|---|---|---|
| Q4 2023 | Feb 28, 2024 | +0.8% |
| Q3 2023 | Nov 20, 2023 · After close | −3.1% |
| Q2 2023 | Aug 30, 2023 | +0.7% |
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| 2026 ILADS Annual Scientific Conference | Conference | 29 slides | Oct 23, 2026 |
| Technical Presentation (October 2026) | Technical | 18 slides | Oct 6, 2026 |
| H.C. Wainwright Presentation September 2026 | Conference | 19 slides | Sep 8, 2026 |
| Investor Presentation (July 2026) | Investor deck | 30 slides | Jul 20, 2026 |
| Investor Presentation (January 2026) | Investor deck | 26 slides | Jan 8, 2026 |
| H.C. Wainwright Presentation, September 2025 | Conference | 24 slides | Sep 9, 2025 |
| H.C. Wainwright Conference (September 2025) | Conference | 19 slides | September 2025 |
Financings
| Raise | Date |
|---|---|
| Private placement of common stock (or pre-funded warrants) with series A and series B warrants Announced: about US$1M · US$1.74 a share · Warrants at US$1.49 · H.C. Wainwright & Co. Dealers: H.C. Wainwright & Co. (lead) Use of proceeds: Working capital and general corporate purposes | Jul 30, 2026 |
| Public offering of shares of common stock (or pre-funded warrants) with Series A-1 and Series A-2 warrants Closed: US$5M raised · US$1.9 a share · Warrants at US$1.9 for 60 months · H.C. Wainwright & Co. Dealers: H.C. Wainwright & Co. (lead) Use of proceeds: Working capital and general corporate purposes | Jul 16, 2025 |
| Registered direct offering of shares of common stock with concurrent private placement of short-term warrants Announced: US$1.07M · US$0.715 a share · Warrants at US$0.59 for 24 months · H.C. Wainwright & Co. Dealers: H.C. Wainwright & Co. (lead) Use of proceeds: Working capital and other general corporate purposes | Feb 5, 2025 |
| Registered direct offering of shares of common stock with concurrent private placement of short-term warrants Announced: US$1.04M · US$1.021 a share · Warrants at US$0.771 for 24 months · H.C. Wainwright & Co. Dealers: H.C. Wainwright & Co. (lead) Use of proceeds: Working capital and other general corporate purposes | Jan 29, 2025 |
Open Financings · Read by 6ix AI from the company's releases
IPO
Priced at US$5.30 a unit on Jul 12, 2023.
- Price
- US$5.30 a unit
- Units offered
- 1,415,095 units
- Offering size
- US$7.5 million
- Underwriters' option
- Up to 212,265 more units
- Listing
- SXTP on the Nasdaq Capital Market
- Underwriter
- WallachBeth Capital LLC
- Units delivered
- On or about Jul 14, 2023
Steps
| Step | When |
|---|---|
| Draft sent to the SEC in confidence | Oct 18, 2022 |
| Filed publicly | Jan 31, 2023 |
| Amended 5 times | Newest Jun 8, 2023 |
| Shares registered with an exchange | Jun 14, 2023 |
| Declared effective by the SEC | Jul 11, 2023 |
| Final prospectus, with the price | Jul 13, 2023 |
Filings
| Filing | Filed |
|---|---|
| 424B4 · Prospectus | Jul 13, 2023 |
| CERT · Exchange's certificate of listing | Jul 12, 2023 |
| EFFECT · Notice that a registration is effective | Jul 11, 2023 |
| CORRESP · Letter to the SEC | Jul 7, 2023 |
| CORRESP · Letter to the SEC | Jul 7, 2023 |
| CORRESP · Letter to the SEC | Jun 27, 2023 |
| 8-A12B/A · Registration of shares for listing on an exchange, amended | Jun 27, 2023 |
| CORRESP · Letter to the SEC | Jun 27, 2023 |
| CORRESP · Letter to the SEC | Jun 27, 2023 |
| CORRESP · Letter to the SEC | Jun 22, 2023 |
All 41 filings
Open IPO · From the cover of the final prospectus (424B4) filed Jul 13, 2023
Financials
Annual, in USD
Income statement
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Revenue | 1.01M | 607.6K | 253.6K | 223.2K | 1.16M | 2.18M |
| Cost of revenue | 781.7K | 384.8K | 474.6K | 432.4K | 850.7K | 703.0K |
| Gross profit | 223.8K | 222.8K | -221.0K | -209.2K | 309.6K | 1.48M |
| Research and development | 2.11M | 4.99M | 691.8K | 525.6K | 5.51M | 806.7K |
| Selling, general and administrative | 6.28M | 5.02M | 4.24M | 1.30M | 1.12M | 1.46M |
| Operating income | -7.76M | -9.72M | -5.15M | -1.75M | -1.12M | -418.1K |
| Depreciation and amortization | 43.3K | 11.7K | 21.2K | 27.6K | 71.8K | 27.9K |
| EBITDA | -7.72M | -9.70M | -5.13M | -1.72M | -1.05M | -390.3K |
| Interest expense | 7.80K | 7.91K | 2.29M | 3.99M | 3.17M | 2.68M |
| Income before tax | -7.37M | -7.96M | -3.81M | -6.18M | -4.26M | -3.05M |
| Income tax | 0 | 0 | 250 | 500 | 1.00K | 1.00K |
| Net income | -7.37M | -7.95M | -3.77M | -6.18M | -4.25M | -3.03M |
| Earnings per share, basic | -11.73 | -74.17 | -59.18 | -2.61 | -175.63 | -125.32 |
| Earnings per share, diluted | -11.73 | -74.17 | -59.18 | -2.61 |
Balance sheet
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Cash and equivalents | 1.51M | 1.66M | 2.14M | 264.9K | 115.4K | 191.7K |
| Short-term investments | 1.24M | 1.73M | ||||
| Receivables | 509.6K | 486.7K | 231.3K | 46.0K | 146.4K | 859.4K |
| Inventory | 656.9K | 442.8K | 466.2K | 518.6K | 689.0K | 1.04M |
| Current assets | 4.90M | 5.39M | 7.24M | 1.10M | 1.18M | 2.44M |
| Property, plant and equipment | 246.4K | 149.8K | 57.8K | 21.3K | 107.6K | |
| Total assets | 5.37M | 5.76M | 7.78M | 1.30M | 1.39M | 2.61M |
| Accounts payable | 668.3K | 1.01M | 506.2K | 758.7K | 588.7K | 1.38M |
| Current liabilities | 1.85M | 1.66M | 2.84M | 23.9M | 635.5K | 1.43M |
| Long-term debt | 144.0K | 147.1K | 150.3K | 16.9M | 18.7M | 15.9M |
| Total debt | 150.0K | 150.0K | 150.0K | 16.9M | 18.8M | 15.9M |
| Total liabilities | 1.99M | 1.80M | 2.99M | 25.4M | 19.5M | 20.7M |
| Shareholders' equity | 3.46M | 4.04M | 4.87M | -23.6M | -17.6M | -17.5M |
| Shares outstanding | 1.16M | 141.7K | 96.8K | 11.6M | 24.2K | 24.2K |
Cash flow
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Cash from operations | -6.85M | -5.65M | -4.54M | -1.01M | -649.1K | -167.3K |
| Capital spending | -139.9K | -103.8K | -57.6K | -60.1K | -35.4K | -71.0K |
| Free cash flow | -6.99M | -5.75M | -4.60M | -1.07M | -684.5K | -238.3K |
| Cash from investing | 254.9K | -1.89M | -115.9K | -60.1K | -35.4K | -71.0K |
| Cash from financing | 6.44M | 7.05M | 6.47M | 1.22M | 611.2K | 277.4K |
| Change in cash | -149.3K | -483.1K | 1.88M | 149.5K | -76.3K | -95.2K |
Filings
| Filing | Date | Type | Filed with |
|---|---|---|---|
| 8-K · Current report | Nov 20, 2026 | Current report | SEC |
| 10-Q · Quarterly report | Nov 16, 2026 | Quarterly report | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Nov 16, 2026 | Big-stake notice | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Nov 12, 2026 | Big-stake notice | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Nov 10, 2026 | Big-stake notice | SEC |
| 8-K · Current report | Nov 6, 2026 | Material contract | SEC |
| 8-K · Current report | Oct 27, 2026 | Current report | SEC |
| 8-K · Current report | Oct 23, 2026 | Current report | SEC |
| 8-K · Current report | Oct 6, 2026 | Current report | SEC |
| 8-K · Current report | Sep 14, 2026 | Current report | SEC |
Show 200 filings
| Filing | Date | Type | Filed with |
|---|---|---|---|
| 8-K · Current report | Sep 8, 2026 | Current report | SEC |
| EFFECT · Notice that a registration is effective | Aug 26, 2026 | Other filings | SEC |
| DEL AM | Aug 17, 2026 | Other filings | SEC |
| S-3 · Registration statement | Aug 14, 2026 | Offer document | SEC |
| 10-Q · Quarterly report | Aug 14, 2026 | Quarterly report | SEC |
| 8-K · Current report | Aug 6, 2026 | Meeting outcome | SEC |
| SCHEDULE 13G · Big-stake notice | Aug 5, 2026 | Big-stake notice | SEC |
| 8-K · Current report | Aug 4, 2026 | Material contract | SEC |
| 3 · Initial statement of ownership | Jul 29, 2026 | Insider trade | SEC |
| SCHEDULE 13G · Big-stake notice | Jul 29, 2026 | Big-stake notice | SEC |
| 8-K · Current report | Jul 20, 2026 | Current report | SEC |
| 8-K · Current report | Jul 9, 2026 | Current report | SEC |
| DEF 14A · Proxy statement | Jul 2, 2026 | Meeting notice | SEC |
| 4 · Change in ownership | Jun 15, 2026 | Insider trade | SEC |
| PRE 14A · Preliminary proxy statement | Jun 8, 2026 | Meeting notice | SEC |
| 8-K · Current report | Jun 3, 2026 | Current report | SEC |
| 3 · Initial statement of ownership | May 19, 2026 | Insider trade | SEC |
| 8-K · Current report | May 18, 2026 | Management or board change | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | May 15, 2026 | Big-stake notice | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | May 15, 2026 | Big-stake notice | SEC |
| 10-Q · Quarterly report | May 15, 2026 | Quarterly report | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | May 13, 2026 | Big-stake notice | SEC |
| 10-K · Annual report | Mar 30, 2026 | Annual report | SEC |
| 8-K · Current report | Mar 20, 2026 | Current report | SEC |
| 424B5 · Prospectus | Mar 13, 2026 | Offer document | SEC |
| 8-K · Current report | Mar 13, 2026 | Current report | SEC |
| 8-K · Current report | Mar 12, 2026 | Current report | SEC |
| 424B5 · Prospectus | Mar 11, 2026 | Offer document | SEC |
| 424B5 · Prospectus | Mar 2, 2026 | Offer document | SEC |
| 8-K · Current report | Feb 12, 2026 | Current report | SEC |
| 8-K · Current report | Jan 23, 2026 | Current report | SEC |
| 8-K · Current report | Jan 21, 2026 | Current report | SEC |
| 8-K · Current report | Jan 8, 2026 | Current report | SEC |
| 4 · Change in ownership | Dec 16, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Dec 12, 2025 | Insider trade | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Nov 13, 2025 | Big-stake notice | SEC |
| 10-Q · Quarterly report | Nov 13, 2025 | Quarterly report | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Nov 7, 2025 | Big-stake notice | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Nov 7, 2025 | Big-stake notice | SEC |
| 8-K · Current report | Oct 10, 2025 | Meeting outcome | SEC |
| 4 · Change in ownership | Sep 15, 2025 | Insider trade | SEC |
| 8-K · Current report | Sep 9, 2025 | Current report | SEC |
| 424B5 · Prospectus | Sep 5, 2025 | Offer document | SEC |
| 8-K · Current report | Sep 5, 2025 | Material contract | SEC |
| DEFR14A | Aug 29, 2025 | Meeting notice | SEC |
| DEF 14A · Proxy statement | Aug 26, 2025 | Meeting notice | SEC |
| PRE 14A · Preliminary proxy statement | Aug 15, 2025 | Meeting notice | SEC |
| 4 · Change in ownership | Aug 14, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Aug 14, 2025 | Insider trade | SEC |
| 3 · Initial statement of ownership | Aug 14, 2025 | Insider trade | SEC |
| 10-Q · Quarterly report | Aug 13, 2025 | Quarterly report | SEC |
| SCHEDULE 13G · Big-stake notice | Jul 22, 2025 | Big-stake notice | SEC |
| SCHEDULE 13G · Big-stake notice | Jul 18, 2025 | Big-stake notice | SEC |
| 8-K · Current report | Jul 18, 2025 | Material contract | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Jul 17, 2025 | Big-stake notice | SEC |
| SCHEDULE 13G · Big-stake notice | Jul 17, 2025 | Big-stake notice | SEC |
| 424B4 · Prospectus | Jul 16, 2025 | Offer document | SEC |
| EFFECT · Notice that a registration is effective | Jul 16, 2025 | Other filings | SEC |
| CORRESP · Letter to the SEC | Jul 10, 2025 | Other filings | SEC |
| CORRESP · Letter to the SEC | Jul 10, 2025 | Other filings | SEC |
| S-1 · Registration statement | Jul 7, 2025 | Offer document | SEC |
| UPLOAD · Letter from the SEC | Jun 13, 2025 | Other filings | SEC |
| 4 · Change in ownership | Jun 9, 2025 | Insider trade | SEC |
| DRS · Draft registration statement | Jun 6, 2025 | Offer document | SEC |
| 4 · Change in ownership | Jun 5, 2025 | Insider trade | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | May 15, 2025 | Big-stake notice | SEC |
| 10-Q · Quarterly report | May 15, 2025 | Quarterly report | SEC |
| SCHEDULE 13G · Big-stake notice | May 14, 2025 | Big-stake notice | SEC |
| 8-K · Current report | Apr 9, 2025 | Current report | SEC |
| EFFECT · Notice that a registration is effective | Apr 3, 2025 | Other filings | SEC |
| CORRESP · Letter to the SEC | Mar 31, 2025 | Other filings | SEC |
| S-1/A · Registration statement, amended | Mar 27, 2025 | Offer document | SEC |
| 10-K · Annual report | Mar 27, 2025 | Annual report | SEC |
| UPLOAD · Letter from the SEC | Feb 19, 2025 | Other filings | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Feb 14, 2025 | Big-stake notice | SEC |
| S-1 · Registration statement | Feb 14, 2025 | Offer document | SEC |
| D | Feb 11, 2025 | Other filings | SEC |
| D | Feb 11, 2025 | Other filings | SEC |
| SCHEDULE 13G · Big-stake notice | Feb 11, 2025 | Big-stake notice | SEC |
| 8-K · Current report | Feb 6, 2025 | Material contract | SEC |
| 424B5 · Prospectus | Feb 6, 2025 | Offer document | SEC |
| SCHEDULE 13G · Big-stake notice | Feb 3, 2025 | Big-stake notice | SEC |
| 8-K · Current report | Jan 30, 2025 | Material contract | SEC |
| 424B5 · Prospectus | Jan 30, 2025 | Offer document | SEC |
| 8-K · Current report | Jan 28, 2025 | Current report | SEC |
| 4 · Change in ownership | Jan 24, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jan 24, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jan 21, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jan 21, 2025 | Insider trade | SEC |
| 8-K · Current report | Jan 8, 2025 | Current report | SEC |
| 4 · Change in ownership | Dec 18, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Dec 9, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Nov 21, 2024 | Insider trade | SEC |
| SC 13G · Big-stake notice | Nov 14, 2024 | Big-stake notice | SEC |
| 10-Q · Quarterly report | Nov 14, 2024 | Quarterly report | SEC |
| SC 13G/A · Big-stake notice, amended | Nov 13, 2024 | Big-stake notice | SEC |
| 8-K · Current report | Nov 6, 2024 | Meeting outcome | SEC |
| DEF 14A · Proxy statement | Oct 15, 2024 | Meeting notice | SEC |
| 8-K · Current report | Oct 8, 2024 | Current report | SEC |
| PRE 14A · Preliminary proxy statement | Oct 2, 2024 | Meeting notice | SEC |
| EFFECT · Notice that a registration is effective | Oct 1, 2024 | Other filings | SEC |
| CORRESP · Letter to the SEC | Sep 26, 2024 | Other filings | SEC |
| UPLOAD · Letter from the SEC | Sep 24, 2024 | Other filings | SEC |
| S-3 · Registration statement | Sep 19, 2024 | Offer document | SEC |
| 4 · Change in ownership | Sep 11, 2024 | Insider trade | SEC |
| 8-K · Current report | Sep 6, 2024 | Material contract | SEC |
| 8-K · Current report | Aug 28, 2024 | Current report | SEC |
| 8-K · Current report | Aug 14, 2024 | Current report | SEC |
| 10-Q · Quarterly report | Aug 14, 2024 | Quarterly report | SEC |
| 8-K · Current report | Aug 12, 2024 | Current report | SEC |
| 424B5 · Prospectus | Aug 2, 2024 | Offer document | SEC |
| 8-K · Current report | Jul 26, 2024 | Current report | SEC |
| 424B5 · Prospectus | Jul 26, 2024 | Offer document | SEC |
| 424B5 · Prospectus | Jul 24, 2024 | Offer document | SEC |
| 424B5 · Prospectus | Jul 22, 2024 | Offer document | SEC |
| EFFECT · Notice that a registration is effective | Jul 19, 2024 | Other filings | SEC |
| 8-K · Current report | Jul 16, 2024 | Meeting outcome | SEC |
| CORRESP · Letter to the SEC | Jul 16, 2024 | Other filings | SEC |
| UPLOAD · Letter from the SEC | Jul 15, 2024 | Other filings | SEC |
| S-3 · Registration statement | Jul 12, 2024 | Offer document | SEC |
| 8-K · Current report | Jul 9, 2024 | Current report | SEC |
| 8-K · Current report | Jun 27, 2024 | Current report | SEC |
| 8-K · Current report | Jun 12, 2024 | Current report | SEC |
| DEF 14A · Proxy statement | May 30, 2024 | Meeting notice | SEC |
| 4 · Change in ownership | May 21, 2024 | Insider trade | SEC |
| 4 · Change in ownership | May 21, 2024 | Insider trade | SEC |
| 4 · Change in ownership | May 21, 2024 | Insider trade | SEC |
| 4 · Change in ownership | May 21, 2024 | Insider trade | SEC |
| 4 · Change in ownership | May 21, 2024 | Insider trade | SEC |
| 4 · Change in ownership | May 21, 2024 | Insider trade | SEC |
| 10-Q · Quarterly report | May 15, 2024 | Quarterly report | SEC |
| SC 13G/A · Big-stake notice, amended | May 7, 2024 | Big-stake notice | SEC |
| PRE 14A · Preliminary proxy statement | May 3, 2024 | Meeting notice | SEC |
| 8-K · Current report | May 2, 2024 | Current report | SEC |
| 4 · Change in ownership | Apr 3, 2024 | Insider trade | SEC |
| 10-K · Annual report | Apr 1, 2024 | Annual report | SEC |
| 8-K · Current report | Mar 14, 2024 | Current report | SEC |
| 8-K · Current report | Feb 27, 2024 | Current report | SEC |
| 8-K · Current report | Feb 20, 2024 | Material contract | SEC |
| 4 · Change in ownership | Feb 2, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Feb 2, 2024 | Insider trade | SEC |
| 8-K · Current report | Feb 1, 2024 | Material contract | SEC |
| 424B4 · Prospectus | Jan 30, 2024 | Offer document | SEC |
| EFFECT · Notice that a registration is effective | Jan 30, 2024 | Other filings | SEC |
| CORRESP · Letter to the SEC | Jan 26, 2024 | Other filings | SEC |
| CORRESP · Letter to the SEC | Jan 26, 2024 | Other filings | SEC |
| CORRESP · Letter to the SEC | Jan 26, 2024 | Other filings | SEC |
| CORRESP · Letter to the SEC | Jan 22, 2024 | Other filings | SEC |
| CORRESP · Letter to the SEC | Jan 22, 2024 | Other filings | SEC |
| 8-K · Current report | Jan 22, 2024 | Current report | SEC |
| S-1 · Registration statement | Jan 22, 2024 | Offer document | SEC |
| UPLOAD · Letter from the SEC | Jan 18, 2024 | Other filings | SEC |
| 8-K · Current report | Jan 16, 2024 | Current report | SEC |
| DRS · Draft registration statement | Jan 12, 2024 | Offer document | SEC |
| SC 13G · Big-stake notice | Dec 18, 2023 | Big-stake notice | SEC |
| 3 · Initial statement of ownership | Dec 18, 2023 | Insider trade | SEC |
| 10-Q · Quarterly report | Nov 20, 2023 | Quarterly report | SEC |
| NT 10-Q · Late filing notice | Nov 15, 2023 | Explanation request | SEC |
| 8-K · Current report | Nov 3, 2023 | Current report | SEC |
| 8-K · Current report | Oct 12, 2023 | Current report | SEC |
| 8-K · Current report | Sep 18, 2023 | Current report | SEC |
| 10-Q · Quarterly report | Aug 25, 2023 | Quarterly report | SEC |
| 8-K · Current report | Jul 17, 2023 | Material contract | SEC |
| SEC STAFF LETTER | Jul 17, 2023 | Other filings | SEC |
| 424B4 · Prospectus | Jul 13, 2023 | Offer document | SEC |
| 4 · Change in ownership | Jul 12, 2023 | Insider trade | SEC |
| 4 · Change in ownership | Jul 12, 2023 | Insider trade | SEC |
| CERT · Exchange's certificate of listing | Jul 12, 2023 | Other filings | SEC |
| EFFECT · Notice that a registration is effective | Jul 12, 2023 | Other filings | SEC |
| 3 · Initial statement of ownership | Jul 11, 2023 | Insider trade | SEC |
| 3 · Initial statement of ownership | Jul 11, 2023 | Insider trade | SEC |
| 3 · Initial statement of ownership | Jul 11, 2023 | Insider trade | SEC |
| 3 · Initial statement of ownership | Jul 11, 2023 | Insider trade | SEC |
| 3 · Initial statement of ownership | Jul 11, 2023 | Insider trade | SEC |
| 3 · Initial statement of ownership | Jul 11, 2023 | Insider trade | SEC |
| 3 · Initial statement of ownership | Jul 11, 2023 | Insider trade | SEC |
| 3 · Initial statement of ownership | Jul 11, 2023 | Insider trade | SEC |
| 3 · Initial statement of ownership | Jul 11, 2023 | Insider trade | SEC |
| CORRESP · Letter to the SEC | Jul 7, 2023 | Other filings | SEC |
| CORRESP · Letter to the SEC | Jul 7, 2023 | Other filings | SEC |
| CORRESP · Letter to the SEC | Jun 27, 2023 | Other filings | SEC |
| 8-A12B/A · Registration of shares for listing on an exchange, amended | Jun 27, 2023 | Other filings | SEC |
| CORRESP · Letter to the SEC | Jun 27, 2023 | Other filings | SEC |
| CORRESP · Letter to the SEC | Jun 27, 2023 | Other filings | SEC |
| CORRESP · Letter to the SEC | Jun 22, 2023 | Other filings | SEC |
| CORRESP · Letter to the SEC | Jun 16, 2023 | Other filings | SEC |
| CORRESP · Letter to the SEC | Jun 16, 2023 | Other filings | SEC |
| CORRESP · Letter to the SEC | Jun 14, 2023 | Other filings | SEC |
| 8-A12B/A · Registration of shares for listing on an exchange, amended | Jun 14, 2023 | Other filings | SEC |
| 8-A12B · Registration of shares for listing on an exchange | Jun 13, 2023 | Other filings | SEC |
This page holds 200 of 228 filings. Open Filings
Cap table
Built by 6ix from 60 Degrees Pharmaceuticals, Inc.’s releases · as of Nov 16, 2026
- Common shares
- 4,484,622
- Fully diluted
- 4,484,622
Fully diluted
| Line | Shares | As of |
|---|---|---|
| Common shares | 4,484,622 | Nov 16, 2026 |
Warrants and options
| Lot |
|---|
| Warrants · US$1.90 · expire about Jul 2030 |
Share count over time
| Count | Shares |
|---|---|
| Nov 16, 2026 | 4,484,622 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Eric Francois Other companies: CERo Therapeutics Holdings, Inc. (Director · Since at least Feb 13, 2026); CervoMed Inc. (Director · Jun 25, 2021 – Jul 1, 2021 · Past); Scynexis, Inc. (Chief Financial Officer · Nov 1, 2015 – Jan 29, 2021 · Past) | Director · Since at least May 13, 2026 |
| Charles Allen Other companies: BTCS Inc. (CEO and Chairman of the Board · Since at least Feb 7, 2014) | Director · Since at least Jul 11, 2023 |
| Bryan Smith | Chief Medical Officer · Since at least Jul 11, 2023 |
| Cheryl Xu | Director · Since at least Jul 11, 2023 |
| Geoffrey Dow | Chief Executive Officer & President · Since at least Jul 11, 2023 |
| Kristen Landon | Chief Commercial Officer · Since at least Sep 26, 2024 |
| Paul Field | Director · Since at least Dec 31, 2023 |
| Stephen Toovey | Director · Since at least Jul 11, 2023 |
| Tyrone Miller | Chief Financial Officer · Since at least Nov 4, 2026 |
Log in to ask 6ix AI your own questions about 60 Degrees Pharmaceuticals, Inc.